Indivior Pharmaceuticals, Inc. (INDV) Profit Breakdown
- 2026-06-30: Reportable $294.00M.
- 2025-06-30: Reportable $250.00M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Profit by product
Gross profit: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $294.00M |
|---|
| 2025-06-30 | $250.00M |
|---|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $160.00M |
|---|
| 2025-06-30 | $62.00M |
|---|
Net Income (Loss) Attributable to Parent: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $122.00M |
|---|
| 2025-06-30 | $18.00M |
|---|
Operating income: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $160.00M |
|---|
| 2025-06-30 | $72.00M |
|---|